| Product |
Cat# |
IFU |
Incubation |
Stand.Range/Sensitivity |
Specimen |
Type |
Method |
Units |
| Cortisol |
CLA4651 |
IFU |
30 / 10 - 15 min |
0.5 - 60 ug/dL /// 0.15 ug/dl |
20 ul serum |
quantitative |
MTPL |
96 wells |
| Cortisol (serum) CLA |
CLA4666 |
IFU |
30 / 10 min |
20-800 ng/ml /// 0.48 ng/ml |
20 ul serum |
quantitative |
MTPL |
96 wells |
| CMV IgG (Cytomegalovirus) |
EIA3468 |
IFU |
60 min 37C; 30 / 15 min RT |
pos. / neg. control |
10 ul ser./plasma (1+100 dilut.) |
qual.+semiquant |
MTPL |
96 wells |
| CMV IgM CLA |
CLA5196 |
|
30min 37C / 30 / 15 min. RT |
3 standards, range 50 - 400 DU/mL |
10 ul ser., plasm (1+100 dilut.) |
quantitative |
MTPL |
96 wells |
| C-Peptide |
EIA1293 |
IFU |
270 min. at RT |
0.2-16 ng/ml |
serum, plasma, urine |
quantitative |
MTPL |
96 wells |
| Cotinine (urine) EIA |
EIA1377 |
IFU |
30/30 min. at RT |
neg/pos control |
urine |
qualitative |
MTPL |
96 wells |
| CA 125 (Ovarian Cancer) Antigen |
EIA1472 |
IFU |
3 hrs. at 37 C. |
5 U/ml |
serum |
quantitative |
MTPL |
96 wells |
| CA 15-3 (Breast Cancer) Antigen (BCA) |
EIA1473 |
IFU |
120 min. at 37 C. |
5 U/ml |
serum |
quantitative |
MTPL |
96 wells |
| CA 19-9 (Gastrointestinal Cancer) Antigen (GCA) |
EIA1474 |
IFU |
120 min. at 37 C. |
5 U/ml |
serum |
quantitative |
MTPL |
96 wells |
| Corticotropin Releasing Factor (human - rat - mouse) |
EIA1631 |
IFU |
4 hrs. at RT |
0.2-2.0 ng/ml |
plasma |
quantitative |
MTPL |
96 wells |
| Calcitonin (salmon) |
EIA1636 |
IFU |
4 hrs. at RT |
0.2 ng/ml |
plasma |
quantitative |
MTPL |
96 wells |
| CMV IgM |
EIA1796 |
IFU |
90 min at RT |
|
serum |
quantitative |
MTPL |
96 wells |
| CMV IgG |
EIA1797 |
IFU |
90 min at RT |
|
serum |
quantitative |
MTPL |
96 wells |
| CEA |
EIA1868 |
IFU |
60 / 15 min. |
0 - 100 ng/ml // 0.44 ng/ml |
50 ul serum / plasma |
quantitative |
MTPL |
96 wells |
| CEA |
EIA1871 |
IFU |
80 min. at RT |
1.0 ng/ml |
serum |
quantitative |
MTPL |
96 wells |
| Cortisol (human) |
EIA1887 |
IFU |
1 hour @ RT |
2,5 ng/ml |
serum / plasma |
quantitative |
MTPL |
96 wells |
| CRP (C-Reactive Protein) |
EIA1952 |
IFU |
30/10/30 min. |
0-100 ug/ml 1ug/ml |
human serum and plasma |
quantitative |
MTPL |
96 wells |
| Cyclic AMP |
EIA2096 |
IFU |
|
|
|
quantitative |
MTPL |
192 wells |
| Cyclic GMP |
EIA2097 |
IFU |
|
|
|
quantitative |
MTPL |
192 wells |
| Cysticercosis |
EIA2905 |
IFU |
|
|
|
quantitative |
MTPL |
96 wells |
| Chlamydia IgG (pneumoniae) |
EIA2940 |
IFU |
|
|
|
qualitative |
MTPL |
96 wells |
| Chlamydia IgM (pneumoniae) |
EIA2941 |
IFU |
|
|
|
qualitative |
MTPL |
96 wells |
| Chlamydia IgA (pneumoniae) |
EIA2942 |
IFU |
|
|
|
qualitative |
MTPL |
96 wells |
| Cortisol (urinary) EIA |
EIA2989 |
IFU |
|
|
|
quantitative |
MTPL |
96 wells |
| C1q CIC Elisa |
EIA3169 |
IFU |
30/30/15 min. at 37 C |
2 Standards ( high/low), concentration : 16y/ml and 64y/ml of hu |
100 ul diluted Serum, Plasma |
quantitative |
MTPL |
96 wells |
| C3d CIC Elisa |
EIA3170 |
IFU |
30/30/15 min. at 37 C |
2 Standards (high/low), human aggregate IgG, |
100 ul diluted Serum, Plasma |
quantitative |
MTPL |
96 wells |
| Cotinine (serum) EIA |
EIA3242 |
IFU |
30/30 min. |
10 - 50 ng/ml |
serum or plasma samples |
semi-quant. (3ca |
MTPL |
96 wells |
| C5a (Anaphylatoxin/Complement Component) EIA |
EIA3327 |
IFU |
20/15 min. at 37 C/ min. at RT |
Standard range: 0.1 - 10ug/L |
human plasma or urine |
quantitative |
MTPL |
192 wells |
| Candida albicans IgA (11/11/10 temporarily not available) use EIA3820 |
EIA3457 |
IFU |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative/semi |
MTPL |
96 wells |
| Candida albicans IgG |
EIA3458 |
IFU |
60 min 37 C; 30 / 15 min. RT |
pos./ neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
| Candida albicans IgM |
EIA3459 |
IFU |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
| Chlamydia IgA (trachomatis) |
EIA3461 |
IFU |
60 min 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
| Chlamydia IgG (trachomatis) |
EIA3462 |
IFU |
60 min. 37 C; 30 / 15 min. RT |
pos. / neg. / cut off control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
| Chlamydia IgM (trachomatis) |
EIA3463 |
IFU |
60 min. 37C; 30 / 15 min. RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
| Cryptosporidium Ag (stool) (NOT FOR SALE IN THE USA) |
EIA3467 |
|
30 / 5 / 5 / 5 min. |
pos. / neg. control // 93 % |
stool |
qualitative |
MTPL |
96 wells |
| CMV IgM (Cytomegalovirus) |
EIA3469 |
IFU |
60 min 37C; 30 / 15 min RT |
pos. / neg. control |
10 ul serum (1+100 diluted) |
qualitative |
MTPL |
96 wells |
| Centromer B, anti- Elisa |
EIA3569 |
IFU |
|
|
|
quantitative |
MTPL |
96 wells |
| Cardiolipin IgG/IgM anti- Elisa |
EIA3587 |
IFU |
60' RT |
igG:0-120 GPL-U/ml IgM: 0-80 MPL/U/ml / 1GPL-U/ml (IgG) 0.5 MP |
10 ul serum or plasma |
quantitative |
MTPL |
96 wells |
| Cardiolipin Screen IgG/IgM anti- Elisa |
EIA3589 |
IFU |
|
|
|
quantitative |
MTPL |
96 wells |
| Cathepsin G, anti- Elisa |
EIA3600 |
IFU |
|
|
|
quantitative |
MTPL |
96 wells |
| Calcitonin |
EIA3648 |
IFU |
4 hrs |
1 pg / mL |
human serum |
quantitative |
MTPL |
96 wells |
| Cortistatin-14 (rat) |
EIA3802 |
IFU |
|
|
|
quantitative |
MTPL |
96 wells |
| CD23 (soluble) Elisa |
EIA3874 |
IFU |
2h/30min |
1 - 20 U/mL 0.15U/mL |
50 ul serum |
quantitative |
MTPL |
96 wells |
| Chlamydia IgG (pneumoniae) |
EIA3912 |
IFU |
1 h 37 C / 30', 15' RT |
pos. + neg. control |
10 ul serum or plasma |
qualitative |
MTPL |
96 wells |
| Chlamydia IgM (pneumoniae) |
EIA3913 |
IFU |
1 h 37 C / 30', 15' RT |
pos. + neg. control |
10 ul serum or plasma |
qualitative |
MTPL |
96 wells |
| CRP, HS (C-Reactive Protein) |
EIA3954 |
IFU |
|
|
|
quantitative |
MTPL |
96 wells |
| CH 50 |
EIA3989 |
IFU |
120/15 min |
controls qualitative |
50 ul serum |
qualitative |
MTPL |
96 wells |
| CEA |
EIA4096 |
IFU |
|
|
|
quantitative |
MTPL |
96 wells |
| CK-MB |
EIA4112 |
IFU |
|
|
|
quantitative |
MTPL |
96 wells |
| CagA |
EIA4138 |
IFU |
60/30/15 min |
0-240 RU/ml //sensit. vs Western Blot: 93.7 % |
100 ul serum (1:300 diluted) |
qualitative |
MTPL |
96 wells |